|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001-7400 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Chicago |
State | DE |
Zip Code | 60611-5885 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
TYPE OF REPORT | 8. Year | 2016 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: George E. Cox III, JD |
Date | 7/20/2016 10:38:07 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
S. 2943, National Defense Authorization Act for Fiscal Year 2017, provisions relating to telemedicine and licensure
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Dana |
Lichtenberg |
|
|
|
Thomas |
Roberge |
|
|
|
George |
Cox |
III |
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
Higher Education Reauthorization
Graduate Medical Education
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Thomas |
Roberge |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S. 1945, Mental Health Reform Act of 2015, all provisions
H.R. 2646, Helping Families in Mental Health Crisis Act of 2015, all provisions
H.R. 293, To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes, all provisions
H.R. 2536, Recovery Enhancement for Addiction Treatment (TREAT) Act, all provisions
S. 1455, Recovery Enhancement for Addiction Treatment (TREAT) Act, all provisions
H.R. 1725, National All Schedules Prescription Electronic Reporting (NASPER) Reauthorization Act of 2015, all provisions
S. 480, National All Schedules Prescription Electronic Reporting (NASPER) Reauthorization Act of 2016, all provisions
H.R. 5046, Comprehensive Opioid Abuse Reduction Act of 2016, all provisions
S. 524, Comprehensive Addiction and Recovery Act of 2016, all provisions
H.R. 4586, Lali's Law, all provisions
H.R. 1270, Restoring Access to Medication Act of 2015, all provisions
S. 709, Restoring Access to Medication Act of 2015, all provisions
H.R. 6, 21st Century Cures Act, provisions relating to transparency reporting, all provisions
S. 2978, Protect Continuing Physician Education and Patient Care Act, all provisions
S. 3077, Marijuana Effective Drug Studies (MEDS) Act of 2016, all provisions
H.R. 5395, Expanding Capacity for Health Outcomes (ECHO) Act, all provisions
S. 2873, Expanding Capacity for Health Outcomes (ECHO) Act, all provisions
S. 779, Fair Access to Science and Technology Research Act of 2015, all provisions
H.R. 4641, To provide for the establishment of an inter-agency task force to review, modify, and update best practices for pain management and prescribing pain medication, and for other purposes, all provisions
H.R. 4063, Jason Simcakoski PROMISE Act, all provisions
H.R. 4969, John Thomas Decker Act of 2016, all provisions
H.R. 4985, Kingpin Designation Improvement Act of 2016, all provisions
H.R. 5052, Opioid Program Evaluation (OPEN) Act, all provisions
H.R. 4843, Infant Plan of Safe Care Improvement Act, all provisions
H.R. 3680, Co-Prescribing to Reduce Overdoses Act of 2016, all provisions
H.R. 4978, Nurturing And Supporting Healthy Babies Act, all provisions
H.R. 3691, Improving Treatment for Pregnant and Postpartum Women Act of 2016, all provisions
H.R. 4599, Reducing Unused Medications Act of 2016, all provisions
H.R. 4976, Opioid Review Modernization Act of 2016, all provisions
H.R. 4982, Examining Opioid Treatment Infrastructure Act of 2016, all provisions
H.R. 4981, Opioid Use Disorder Treatment Expansion and Modernization Act, all provisions
Prescription Drug Diversion
Opioid Abuse/Medication assisted treatment
21st Century Cures/Innovations
Zika Funding
Laboratory Developed Tests (LDT) Guidance
Telemedicine - Interstate Medical Licensure Compact
Health data security
Gun violence research/background checks funding
Sexual violence
EHR/Meaningful Use
Sunshine Act
Health Savings Accounts - Prescription requirements for over-the-counter medications
Prediabetes coverage
Blood pressure monitoring coverage
Compounding
PrecisionFDA
Clinical trials - insurance coverage improvement
HIPAA Regulations
Dietary supplements
EHR/Interoperability
Diabetes Prevention Program (DPP) fees
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Natl Institutes of Health (NIH), Internal Revenue Service (IRS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Matthew |
Reid |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Charles |
Kels |
|
|
|
Ashley |
McGlone |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Insurance Company Mergers
Insurance Market Competition
Antitrust
Drug manufacturers anti-competitive practices
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, Federal Trade Commission (FTC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
George |
Cox |
III |
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 4499, Promoting Responsible Opioid Prescribing (PROP) Act of 2016, all provisions
S. 2758, Promoting Responsible Opioid Prescribing (PROP) Act of 2016, all provisions
H.R. 976, Patient Access to Higher Quality Health Care Act of 2015, all provisions
H.R. 5273, Helping Hospitals Improve Patient Care Act of 2016, all provisions
H.R. 2977, Furthering Access to Stroke Telemedicine (FAST) Act, all provisions
H.R. 21102, Medicare Diabetes Prevention Act of 2015, all provisions
S. 1131, Medicare Diabetes Prevention Act of 2015, all provisions
H.R. 1470, SGR Repeal and Medicare Provider Payment Modernization Act of 2015, provisions relating to delivery and payment reform
S. 810, SGR Repeal and Medicare Provider Payment Modernization Act of 2015, provisions relating to delivery and payment reform
H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015, all provisions
H.R. 4442, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act, all provisions
S. 2484, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act, all provisions
S. 1913, Stopping Medication Abuse and Protecting Seniors Act of 2015, all provisions
H.R. 1608, Lymphedema Treatment Act, all provisions
S. 2373, Lymphedema Treatment Act, all provisions
S. 2943, National Defense Authorization Act for Fiscal Year 2017, provisions relating to Telemedicine and licensure
Medicare program: Diabetes prevention
Medicare program: IPAB Repeal
Medicare program: Medicare Access and CHIP Reauthorization Act (MACRA) Implementation
Medicare program: MACRA physician compliance flexibility
Medicare program: Quality Payment Program (QPP)
Medicare program: Protecting Access to Medicare Act (PAMA) implementation
Medicare program: Merit-Based Incentive Payment System (MIPS)
Medicare program: Value-Based Modifier (VBM)
Medicare program: Advancing Care Information (ACI) score
Medicare program: Clinical Practice Improvement Activities (CPIAs)
Medicare program: Resource Use
Medicare program: Alternative Payment Models (APMs)
Medicare program: Physician Quality Reporting System (PQRS)
Medicare program: Graduate Medical Education (GME)
Medicare program: Prescription Drug Diversion/Opioid abuse
Medicare program: Physician data
Medicare program: Adding unique device identifier to billing form
Medicare program: Physician-owned hospital moratorium
Medicare program: Physician Office-based Labs (POLS)
Medicare program: EHR/Meaningful Use
Medicare program: Sunshine Act
Medicare program: Part B Drug Demonstration/Reimbursement
Medicare program: In-Office Ancillary Services Exception
Medicare program: Provider networks adequacy and balance billing
Medicare program: AHIP-CMS Core Measure activity
Medicare program: Comprehensive joint replacement
Medicare program: Chronic care
Medicare program: Home health prior authorization
Medicare program: Telehealth
Medicare program: Clinical Trials - insurance coverage improvements
Medicare program: Coverage policy
Medicare program: Program Integrity/Provider Enrollment
Medicare and Medicaid programs: EHR interoperability/digital health
Medicaid program: State Medicaid cuts
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Office of Management & Budget (OMB), White House Office, Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Medicare Payment Advisory Commission (MedPAC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Charles |
Kels |
|
|
|
Ashley |
McGlone |
|
|
|
Kristen |
O'Brien |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Cigars/FDA oversight exemption
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
H.R. 865, Good Samaritan Health Professionals Act of 2015, all provisions
H.R. 5048, Good Samaritan Assessment Act of 2016, all provisions
S. 2943, National Defense Authorization Act for Fiscal Year 2017, provisions relating to telemedicine liability
Telemedicine
Medical Liability Reform
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Charles |
Kels |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
H.R. 1604, Veterans' Mental Health Care Access Act, all provisions
S. 2896, Care Veterans Deserve Act of 2016, all provisions
H.R. 1818, Veteran Emergency Medical Technician Support Act of 2016
S. 2170, Veterans E-Health and Telemedicine Support (VETS) Act of 2015, all provisions
S. 2943, National Defense Authorization Act for Fiscal Year 2017, provisions relating to Telemedicine and licensure
H.R. 4442, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act, provisions relating to telehealth
S. 2484, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act, provisions relating to telehealth
VA CHOICE Program
VA nursing handbook
Scope of Practice
TRICARE
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IND
16. Specific lobbying issues
Sexual violence against Native American and Alaska Native women
17. House(s) of Congress and Federal agencies Check if None
Centers For Disease Control & Prevention (CDC), Indian Health Service
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |